Fluoroscopy and Mobile C-Arms Market Advancement Outlook | Market demand 2022
Market
Overview
Fluoroscopy
can be defined as an imaging technique, which uses X-Ray technology for taking
real-time images of the body. It allows the physicians to visualize muscles,
organs, and bones, which further helps them to make crucial decisions during
surgery. Fluoroscopy and Mobile C-Arms Market is anticipated to reach USD
3,792.32 Million by 2030 at 4.20% CAGR during the forecast period
2022-2030.
Factors
like the rising incidence of chronic diseases, ever-increasing geriatric
population, and high adoption of fluoroscopy in neurological and orthopedic
procedures will supplement the market growth in the segment. Improving
healthcare infrastructure, advancing technology in fluoroscopy and C-arms
equipment, and increasing number of interventional radiology surgeries are
likely to elevate the scope for the market across the globe. Moreover, rapid
product launches and rising number of mergers and acquisitions will further
contribute to the market growth in the long run. The shift towards a
value-based healthcare model, surging adoption of minimally invasive surgeries,
and soaring demand for improved imaging technology are likely to promote the
market growth in the coming years.
On the
contrary, the high cost of fluoroscopic and mobile c-arm systems,
coupled with the risk of radiation exposure are some of the key concerns likely
to restrict the market growth across the globe.
Competitive
Dashboard
The top
operating in the Fluoroscopy and Mobile C-Arms Market
Players scope include
Canon Medical Systems Corporation (Japan), Allengers Medical Systems (India),
GE Healthcare (US), DMS Group (France), Hologic Inc. (US), Hitachi Ltd (Tokyo),
OrthoScan, Inc. (the US), Omega Medical Imaging, LLC (US), Shimadzu Corporation
(Japan), Koninklijke Philips N.V. (The Netherlands), Varian Medical Systems,
Inc. (US), Siemens (Germany), Ziehm Imaging GmbH (US), and Villa Sistemi
Medicali Spa (Italy).
Global
Fluoroscopy and Mobile C-Arms Market: Segmental Analysis
The
fluoroscopy and mobile C-arms market analysis has been segmented on the basis
of application, device type, and end user.
·
By device type,
the market is segmented into fluoroscopy systems and mobile c-arms. Of these,
the mobile C-arms segment will gain significant prominence, mainly due to the
soaring incidence of cardiovascular disease and the rising number of orthopedic
surgeries. C-arms are extensively used for surgeries of cardiovascular
diseases, gastroenterology, neurosurgeries, traumatology, orthopedics, and
urology disorders.
·
The market finds application in orthopedics, gastrointestinal, cardiovascular, pain
management and trauma, urology, neurology, and others. Of these, the
cardiovascular application will gain prominence due to the increased burden of
cardiovascular diseases and better results offered by fluoroscopy systems
during treatment and diagnosis.
·
Based on the end users, the market constitutes diagnostic centers, hospital and clinics,
research and academic institutes, and others. Of these, the hospital and
clinics segment accounted for USD 895.96 million in 2017. The high adoption of
advanced and sophisticated imaging systems will drive the market growth in the
segment.
Regional
Frontiers
Geographically,
the fluoroscopy and mobile C-arms market fhave been studied under regions
namely, Europe, the Americas, Asia Pacific, and the Middle East & Africa.
Considering
the global scenario, the Americas is predicted to acquire the lion’s share and
dominate the market globally. In this region, North America is predicted to
command the largest share, mainly due to the acceptance of innovative and
latest products. Also, the surging awareness regarding medical imaging devices
and rising financial capability to purchase expensive machines are driving the
market growth in the region.
Europe is
likely to register moderate growth in the foreseeable future. The regional
growth can be credited to the surging prevalence of road accidents, which leads
to orthopedic surgeries. The rising expenditure in the healthcare sector and
increasing R&D activities will further contribute to the market growth in
the long run.
Meanwhile,
the Asia Pacific will register the fastest growth across the globe. Developing
countries like India, China, and South Korea are gradually becoming major
destinations for pathology testing and outsourcing clinical trials. This is
likely to elevate the scope of the market in the region. The presence of
untapped opportunities, surging awareness about medical imaging techniques and
applications, and improving healthcare infrastructure are encouraging the
regional market’s growth.
Industry
Updates
·
September
2019: ControlRad has recently announced the completion of the first clinical
use of its Trace system. This Atlanta-based ControlRad’s Trace technology can
be easily integrated into mobile C-arms. It assists in reducing radiation in
fluoroscopically guided procedures and protect medical staff and patients,
without hampering image quality and workflow.
·
Periodontal Therapeutic Market Research
Report – Forecast to 2027
·
Smart Pills Market Research Report -
Forecast to 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment